RxDoctor Payments DataLook up a doctor →

Farhad Kadkhodaei Elyaderani, MD

Clinical Neurophysiology · Bronx, NYNPI 1396972725

Payments from drug & device makers

$156,460in general payments, 2019–2025

Across 2,319 payments — averaging $67.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$98K
  • Pfizer$22K
  • Scilex Pharmaceuticals Inc.$6K
  • AstraZeneca$3K
  • Teva Pharmaceuticals USA, Inc.$3K
  • SK Life Science, Inc.$2K
  • plus $23K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)535$97,618
Pfizer159$22,298
Scilex Pharmaceuticals Inc.122$6,245
AstraZeneca(2 entities)61$2,712
Teva Pharmaceuticals USA, Inc.144$2,504
SK Life Science, Inc.128$2,305
MDD US Operations, LLC83$2,029
Lundbeck LLC66$1,478
Novartis83$1,449
Lilly USA, LLC107$1,361
Amneal Pharmaceuticals LLC68$1,339
Otsuka America Pharmaceutical, Inc.81$1,280
Kyowa Kirin, Inc.47$1,010
Adamas Pharmaceuticals, Inc.65$949
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)37$863
Amgen(2 entities)36$818
Biogen37$670
Neurocrine Biosciences, Inc.27$669
Sunovion Pharmaceuticals Inc.34$636
EMD Serono, Inc.27$615
UCB, Inc.31$612
Avanir Pharmaceuticals, Inc.27$543
Acadia Pharmaceuticals Inc28$477
Sanofi19$415
Vanda Pharmaceuticals Inc.32$406
Sumitomo Pharma America, Inc.21$405
Axsome Therapeutics, Inc.19$365
Takeda Pharmaceuticals U.S.A., Inc.16$359
Argenx US, Inc.18$335
Neurelis, Inc.11$306
GE HealthCare11$268
Biohaven Pharmaceuticals, Inc.9$249
Johnson & Johnson11$239
Biohaven Pharmaceutical Holding Company Ltd.12$228
Idorsia Pharmaceuticals US Inc11$201
TG Therapeutics, Inc.7$182
CSL Behring8$178
Mallinckrodt Enterprises LLC5$159
Eisai Inc.8$154
Avion Pharmaceuticals8$145
E.r. Squibb & Sons, L.L.C.2$143
Genentech USA, Inc.5$105
Acorda Therapeutics, Inc5$89
Baxter Healthcare2$80
Vertical Pharmaceuticals, LLC4$67
Neuronetics, Inc.1$60
Grifols USA, LLC2$59
Akcea Therapeutics, Inc.3$58
Catalyst Pharmaceuticals, Inc.3$56
Boston Scientific1$56
Currax Pharmaceuticals LLC4$54
ANI Pharmaceuticals, Inc.2$52
Alnylam Pharmaceuticals Inc.2$49
Bausch Health US, LLC2$48
Alfasigma USA, Inc.3$39
Corium, LLC1$34
Assertio Therapeutics, Inc.2$33
Upsher-smith Laboratories LLC2$31
Ipsen Biopharmaceuticals, Inc1$30
Ultragenyx Pharmaceutical Inc.1$26

How this compares

$156,460 in reported general payments places this provider in the 95th percentile of 35 clinical neurophysiology providers in New York.

See all clinical neurophysiology providers in New York →

Medicare billing

Part B allowed, 2024
$218,206
Medicare patients
324
Services billed
5,192

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical neurophysiology in Bronx

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →